ReviewArrhythmia & electrophysiology review2026
Catheter Ablation as an Early Rhythm-control Strategy in Patients with Atrial Fibrillation and Heart Failure.
Review in Arrhythmia & electrophysiology review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
AF and heart failure (HF) commonly coexist, and this significantly increases patient morbidity and mortality. Maintaining sinus rhythm is a key treatment goal, as it helps prevent HF progression, improves quality of life and reduces cardiovascular mortality. Catheter ablation (CA) has emerged as an effective and preferred alternative to antiarrhythmic medications for rhythm control in patients with AF and HF. Multiple studies have demonstrated the superiority of CA over medical therapy for maintaining sinus rhythm and improving left ventricular function in the HF population, particularly those with reduced left ventricular ejection fraction. Additionally, CA is associated with a low complication rate due to advancing technology and is cost-effective. With growing evidence and endorsement from recent guidelines, clinical practice has shifted towards early CA in patients with AF and HF. Prioritising early intervention represents a proactive approach to improving long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.